Definitive Healthcare Corp. (DH)
NASDAQ: DH · Real-Time Price · USD
0.79855
-0.0323 (-3.89%)
At close: Jul 1, 2026, 4:00 PM EDT
0.7999
+0.0014 (0.17%)
After-hours: Jul 1, 2026, 4:01 PM EDT

Definitive Healthcare Stock Forecast

Stock Price Forecast

According to 9 analysts polled by S&P Global, Definitive Healthcare stock has a consensus rating of "Hold" and an average price target of $2.20. The average 1-year stock price forecast is 175.50% higher than the current stock price, while the lowest is $0.70 (-12.34%) and the highest is $3.00 (+275.68%).

Price Target: $2.20 (+175.50%)
Analyst Consensus: Hold
TargetLowAverageMedianHigh
Price$0.70$2.20$2.75$3.00
Change-12.34%+175.50%+244.37%+275.68%

Analyst Ratings

The average analyst rating for Definitive Healthcare stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

RatingJan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy333332
Buy000000
Hold888865
Sell111112
Strong Sell000000
Total12121212109

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Bank of America Securities
Bank of America Securities
Sell
Downgrades
$3.5$0.7
SellDowngrades$3.5$0.7-12.34%Jun 29, 2026
Barclays
Barclays
Sell
Reiterates
$1
SellReiterates$1+25.23%Jun 16, 2026
BTIG
BTIG
Hold
Maintains
n/a
HoldMaintainsn/an/aMay 11, 2026
Robert W. Baird
Robert W. Baird
Hold
Maintains
$1.3$1.1
HoldMaintains$1.3$1.1+37.75%May 8, 2026
Needham
Needham
Hold
Reiterates
n/a
HoldReiteratesn/an/aMay 8, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
223.56M
from 241.52M
Decreased by -7.44%
Revenue Next Year
224.95M
from 223.56M
Increased by 0.62%
EPS This Year
0.18
from 0.24
Decreased by -22.96%
EPS Next Year
0.19
from 0.18
Increased by 2.70%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
166.15M222.65M251.42M252.20M241.52M223.56M
Revenue Growth
40.43%34.00%12.92%0.31%-4.23%-7.44%
Gross Profit
146.73M196.79M216.68M211.52M203.57M179.70M
Gross Margin
88.31%88.38%86.18%83.87%84.29%80.38%
Operating Income
-21.03M-36.15M-30.91M-9.74M-20.58M46.01M
Net Income
-51.91M-7.22M-202.39M-413.12M-138.93M-179.20M
EPS
----0.240.18
EPS Growth
-----31.43%-22.96%
Forward PE
117.6552.4832.5813.9811.104.32
Free Cash Flow
54.87M57.76M102.28M71.77M67.93M36.80M
No. Analysts
-----9
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High225.2M
Avg223.6M
Low222.2M

Revenue Growth

Revenue Growth202620272028
High
-6.8%
Avg
-7.4%
Low
-8.0%

EPS Forecast

EPS202620272028
High0.21
Avg0.18
Low0.17

EPS Growth

EPS Growth202620272028
High
-12.5%
Avg
-23.0%
Low
-29.2%